Schonfeld Strategic Advisors »

Silence Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 269k 10.98
2025-03-31 $423k 150k 2.82
2024-12-31 $848k 123k 6.88
2024-09-30 $3.0M 166k 18.18
2024-06-30 $1.4M 75k 19.00
2024-03-31 $2.9M 133k 21.60
2023-12-31 $855k 49k 17.37
2023-09-30 $456k 46k 9.82
2023-06-30 $259k 47k 5.50
2023-03-31 $255k 41k 6.20
2022-12-31 $450k 30k 15.25

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Micron Technology (MU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Msci Brazil Etf (EWZ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vale S A Sponsored Ads (VALE)
Petroleo Brasileiro S A Sponsored Adr (PBR)

View all positions for Schonfeld Strategic Advisors

Top funds holding Silence Therapeutics

Siren
TCG Crossover Management
Redmile Group
Nantahala Capital Management
Citadel Advisors
Polygon Management
Nextech Invest
Millennium Management
Ikarian Capital
Soleus Capital Management
Balyasny Asset Management
5AM Venture Management
Caption Management
Dr. Jeffrey R. Jay, M.D.
Jane Street

View all funds holding Silence Therapeutics